BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2005
View Archived Issues
Fc fragment is not necessary for 1G8's antitumor activity
Read More
Antidepressant efficacy of the selective mGluR5 antagonist, MTEP, shown in rodents
Read More
Peregrine evaluating Tarvacin Anti-Viral for influenza
Read More
In vivo efficacy of SL-65.0155 in Alzheimer's model
Read More
Rigel and Serono sign Aurora kinase inhibitor agreement
Read More
Cardiome Pharma completes acquisition of Artesian Therapeutics
Read More
Solbec selects tumor targets for trials of Coramsine
Read More
Surfaxin complete response accepted, new sublicense agreement signed
Read More
Epitan tests topical formulation of EPT-1647
Read More
FASgen awarded SBIR grant for work in obesity and metabolic disorders
Read More
Phase II trial discontinued for KOS-862 in hormone refractory prostate cancer
Read More
Aroplatin begins phase I study in solid tumors and B-cell lymphoma
Read More
Xencor raises funds to begin phase I trial of XPro1595
Read More
Enrollment stopped in phase III studies of ONO-4128
Read More
Revlimid MAA accepted for review
Read More
FDA to review iPlex complete response
Read More
MHRA accepts for review Dyoject MAA
Read More
SGX receives fast track status for Troxatyl for AML
Read More
Priority review granted for Rituxan sBLA
Read More
New data on the analgesic effects of gabapentin
Read More
Belatacept reported effective in renal transplant recipients at higher risk of CAN
Read More
Adjunctive levetiracetam reduces primary tonic-clonic seizures in patients with IGE
Read More
RJR-2403 assessed in Alzheimer's disease model
Read More
LY-156735 improves sleep parameters in moderate to severe insomnia
Read More
Reversal of neuromuscular block achieved with ORG-25969
Read More
Pegaptanib improves visual acuity in patients with diabetic macular edema
Read More
Recent patents disclose novel agents for the treatment of neurological disorders
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Recent Cambridge Biotechnology patent reports novel analgesic agents
Read More